Updated
Reviewed
Dec. 18, 2019

Appendix B: Drug Characteristics Tables

Characteristics of Nucleoside Reverse Transcriptase Inhibitors (NRTIs)

Appendix B, Table 3. Characteristics of Nucleoside Reverse Transcriptase Inhibitors

The older NRTIs ddI and d4T are no longer commonly used in clinical practice and have been removed from this table. Please refer to the July 10, 2019, version of the guidelines (found in the archived guidelines section of ClinicalInfo) or to the FDA product labels for ddI and d4T for information regarding these drugs.

Appendix B, Table 3. Characteristics of Nucleoside Reverse Transcriptase Inhibitorsa
   
   
   
   

Appendix B: Drug Characteristics Tables

Characteristics of Nucleoside Reverse Transcriptase Inhibitors (NRTIs)

Appendix B, Table 3. Characteristics of Nucleoside Reverse Transcriptase Inhibitors

The older NRTIs ddI and d4T are no longer commonly used in clinical practice and have been removed from this table. Please refer to the July 10, 2019, version of the guidelines (found in the archived guidelines section of ClinicalInfo) or to the FDA product labels for ddI and d4T for information regarding these drugs.

Appendix B, Table 3. Characteristics of Nucleoside Reverse Transcriptase Inhibitorsa
   
   
   
   

Download Guidelines